Back to BlackRock, Inc.ELVN
ELVN6 quarters
Position history for BlackRock, Inc.'s holdings in ENLIVEN THERAPEUTICS INC
BlackRock, Inc. holds 3.7M shares of ELVN (ENLIVEN THERAPEUTICS INC), worth $144.4M as of 2026-Q1. The position was increased (+2.0% shares). ELVN represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$144.4M
Current Shares
3.7M
Total Value Change
+$77.7M
Total Shares Change
+719,579
Quarter-by-Quarter History
Other major holders of ELVN: FMR LLC, Polar Capital Holdings Plc